Catheter Precision to Attend and Participate in the 13th Internation Symposium on Left Atrial Appendage
Catheter Precision (VTAK) has announced its participation in the 13th International Symposium on Left Atrial Appendage (ISLAA) taking place on February 7th and 8th, 2025, in Austin, Texas. The symposium is a multi-specialty cardiovascular educational event focusing on left atrial appendage science.
The program will be managed by leading physicians from prestigious institutions including The Kansas City Heart Rhythm Institute, Texas Cardiac Arrhythmia Institute, Los Robles Medical Center, Mayo Clinic, and Mt. Sinai. The event features hands-on demonstrations and product education for electrophysiology fellows.
Catheter Precision will showcase LockeT, their solution for closing large access sites after LAA procedures. CEO David Jenkins highlighted that LockeT offers a safe and effective option for wound closure, enabling cost reduction and same-day hospital discharge.
Catheter Precision (VTAK) ha annunciato la sua partecipazione al 13° Simposio Internazionale sull'Apendice Atriale Sinistro (ISLAA), che si svolgerà il 7 e 8 febbraio 2025 ad Austin, Texas. Il simposio è un evento educativo cardiovascolare multi-specialistico incentrato sulla scienza dell'apendice atriale sinistro.
Il programma sarà gestito da medici di spicco provenienti da istituzioni prestigiose, tra cui il Kansas City Heart Rhythm Institute, il Texas Cardiac Arrhythmia Institute, il Los Robles Medical Center, la Mayo Clinic e il Mt. Sinai. L'evento prevede dimostrazioni pratiche e formazione sui prodotti per i borsisti di elettrofisiologia.
Catheter Precision presenterà LockeT, la sua soluzione per la chiusura di ampi siti di accesso dopo le procedure LAA. Il CEO David Jenkins ha evidenziato che LockeT offre un'opzione sicura ed efficace per la chiusura delle ferite, consentendo la riduzione dei costi e la dimissione ospedaliera nella stessa giornata.
Catheter Precision (VTAK) ha anunciado su participación en el 13° Simposio Internacional sobre el Apéndice Auricular Izquierdo (ISLAA), que se llevará a cabo el 7 y 8 de febrero de 2025 en Austin, Texas. El simposio es un evento educativo cardiovascular de múltiples especialidades centrado en la ciencia del apéndice auricular izquierdo.
El programa será gestionado por médicos líderes de instituciones prestigiosas, incluyendo el Kansas City Heart Rhythm Institute, el Texas Cardiac Arrhythmia Institute, el Los Robles Medical Center, la Mayo Clinic y el Mt. Sinai. El evento contará con demostraciones prácticas y educación sobre productos para los becarios de electrofisiología.
Catheter Precision presentará LockeT, su solución para cerrar grandes sitios de acceso después de los procedimientos LAA. El CEO David Jenkins destacó que LockeT ofrece una opción segura y efectiva para el cierre de heridas, permitiendo la reducción de costos y el alta hospitalaria el mismo día.
Catheter Precision (VTAK)는 2025년 2월 7일과 8일 텍사스 오스틴에서 열리는 제13회 국제 좌심방 부속기 심포지엄 (ISLAA)에 참여할 것이라고 발표했습니다. 이 심포지엄은 좌심방 부속기 과학에 중점을 둔 다분야 심혈관 교육 행사입니다.
프로그램은 Kansas City Heart Rhythm Institute, Texas Cardiac Arrhythmia Institute, Los Robles Medical Center, Mayo Clinic 및 Mt. Sinai와 같은 권위 있는 기관의 저명한 의사들이 관리합니다. 이 행사에서는 전기생리학 연구원들을 위한 실습 시연 및 제품 교육이 진행됩니다.
Catheter Precision은 LAA 절차 후 큰 접근 부위를 닫기 위한 솔루션인 LockeT를 선보일 예정입니다. CEO David Jenkins는 LockeT가 안전하고 효과적인 상처 봉합 옵션을 제공하여 비용 절감과 같은 날 퇴원을 가능하게 한다고 강조했습니다.
Catheter Precision (VTAK) a annoncé sa participation au 13e Symposium International sur l'Appendice Auriculaire Gauche (ISLAA), qui se déroulera les 7 et 8 février 2025 à Austin, Texas. Le symposium est un événement éducatif cardiovasculaire pluridisciplinaire axé sur la science de l'appendice auriculaire gauche.
Le programme sera géré par des médecins de premier plan issus d'institutions prestigieuses, notamment le Kansas City Heart Rhythm Institute, le Texas Cardiac Arrhythmia Institute, le Los Robles Medical Center, la Mayo Clinic et le Mt. Sinai. L'événement comprend des démonstrations pratiques et une formation sur les produits pour les boursiers en électrophysiologie.
Catheter Precision présentera LockeT, sa solution pour fermer de grandes zones d'accès après les procédures LAA. Le PDG David Jenkins a souligné que LockeT offre une option sûre et efficace pour la fermeture des plaies, permettant de réduire les coûts et de sortir de l'hôpital le même jour.
Catheter Precision (VTAK) hat seine Teilnahme am 13. Internationalen Symposium über den linken Vorhofanhang (ISLAA) angekündigt, das am 7. und 8. Februar 2025 in Austin, Texas, stattfindet. Das Symposium ist eine multi-spezialisierte kardiovaskuläre Bildungveranstaltung, die sich auf die Wissenschaft des linken Vorhofanhangs konzentriert.
Das Programm wird von führenden Ärzten renommierten Institutionen wie dem Kansas City Heart Rhythm Institute, dem Texas Cardiac Arrhythmia Institute, dem Los Robles Medical Center, der Mayo Clinic und dem Mt. Sinai geleitet. Die Veranstaltung bietet praktische Demonstrationen und Schulungen für Elektrophysiologie-Stipendiaten.
Catheter Precision wird LockeT präsentieren, ihre Lösung zur Schließung großer Zugangsstellen nach LAA-Verfahren. CEO David Jenkins betonte, dass LockeT eine sichere und effektive Option für die Wundversorgung bietet, die Kostensenkungen und eine Entlassung am selben Tag ermöglicht.
- None.
- None.
FORT MILL, S.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced their attendance at the 13th International Symposium on Left Atrial Appendage (ISLAA). ISLAA will take place on February 7th and 8th, 2025 in Austin, Texas.
The ISLAA meeting is a multi-specialty cardiovascular educational symposium on the frontier science of left atrial appendage (LAA). Over two days, course directors and leading physicians from The Kansas City Heart Rhythm Institute, Texas Cardiac Arrhythmia Institute, Los Robles Medical Center, Mayo Clinic and Mt. Sinai will manage the program and content.
In addition, the ISLAA meeting provides a unique opportunity for hands-on demonstrations and product education for electrophysiology fellows. Catheter Precision will be participating in these sessions to provide fellows an opportunity to try LockeT, ask questions and learn more about the products benefits, which include cost reduction for the hospital and same day hospital discharge.
David Jenkins, CEO of Catheter Precision, said, “ISLAA is a unique meeting because it is a small group of physicians that perform a niche procedure. These left atrial appendage procedures require the use of a large-bore catheter, meaning that the access site is large. Closing these larger wounds can be difficult, but LockeT provides a safe and effective option for closing these large access sites after LAA procedures.”
About LockeT
Catheter Precision’s LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA.
About Catheter Precision
Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products.
Cautionary Note Regarding Forward-Looking Statements
Statements in this press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to substantial risk and uncertainties. Forward-looking statements can be identified by words such as “believe,” “anticipate,” “may,” “might,” “can,” “could,” “continue,” “depends,” “expect,” “expand,” “forecast,” “intend,” “predict,” “plan,” “rely,” “should,” “will,” “may,” “seek,” or the negative of these terms and other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements include, but are not limited to, statements regarding product evaluations at the hospital, and that the purchase order indicates that the hospital and its staff see the value and benefits that LockeT can bring and expectations regarding LockeT evaluations in the coming weeks. The Company’s expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks and changes in circumstances, including but not limited to risks and uncertainties included under the caption “Risk Factors” in the Company’s Form 10-K filed with the SEC and available at www.sec.gov.
The forward-looking statements included in this communication are made only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
CONTACTS:
At the Company
David Jenkins
973-691-2000
info@catheterprecision.com
# # #
FAQ
When and where is Catheter Precision (VTAK) attending the ISLAA symposium?
What product will VTAK demonstrate at ISLAA 2025?
What are the key benefits of VTAK's LockeT product?
Which medical institutions are managing the ISLAA 2025 program where VTAK is participating?
How will VTAK's participation at ISLAA 2025 benefit electrophysiology fellows?
